Cargando…

Animal Models of Parkinson's Disease

Detalles Bibliográficos
Autores principales:	Imai, Yuzuru, Venderova, Katerina, Park, David S., Cai, Huaibin, Schmidt, Enrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246788/ https://www.ncbi.nlm.nih.gov/pubmed/22220287 http://dx.doi.org/10.4061/2011/364328

Ejemplares similares

Animal Models of Parkinson's Disease 2012
por: Imai, Yuzuru, et al.
Publicado: (2012)

Editorial for the Special Issue “Animal Models of Parkinson’s Disease and Related Disorders”
por: Imai, Yuzuru
Publicado: (2020)

Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson’s Disease?
por: Iseki, Tatou, et al.
Publicado: (2023)

Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease
por: Mori, Akio, et al.
Publicado: (2020)

Editorial: Molecular Links Between Mitochondrial Damage and Parkinson's Disease and Related Disorders
por: Imai, Yuzuru, et al.
Publicado: (2021)

Animal Models of Alzheimer's Disease
por: Casadesus, Gemma, et al.
Publicado: (2011)

Animal Models of Human Disease
por: Lange, Sigrun, et al.
Publicado: (2023)

Aminochrome as preclinical model for Parkinson's disease
por: Segura-Aguilar, Juan
Publicado: (2017)

Lipopolysaccharide Animal Models for Parkinson's Disease
por: Liu, Mei, et al.
Publicado: (2011)

Limitations of Animal Models of Parkinson's Disease
por: Potashkin, J. A., et al.
Publicado: (2010)

Animal Model for Prodromal Parkinson’s Disease
por: Taguchi, Tomoyuki, et al.
Publicado: (2020)

Inflammatory Animal Models of Parkinson’s Disease
por: García-Revilla, Juan, et al.
Publicado: (2022)

Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson’s disease mutant of Leucine-rich repeat kinase 2 (LRRK2)
por: Linhart, Radek, et al.
Publicado: (2014)

Familial Parkinson's Disease/Parkinsonism
por: Tomiyama, Hiroyuki, et al.
Publicado: (2015)

Animal Models of Diabetes and Metabolic Disease
por: Sasase, Tomohiko, et al.
Publicado: (2013)

Connectivity and Functionality of the Globus Pallidus Externa Under Normal Conditions and Parkinson's Disease
por: Dong, Jie, et al.
Publicado: (2021)

Double hit mouse model of Parkinson's disease
por: Schirinzi, Tommaso, et al.
Publicado: (2016)

Mitochondria and Parkinson's Disease
por: Simon, David K., et al.
Publicado: (2011)

Diverse midbrain dopaminergic neuron subtypes and implications for complex clinical symptoms of Parkinson’s disease
por: Carmichael, Kathleen, et al.
Publicado: (2021)

Classic and New Animal Models of Parkinson's Disease
por: Blesa, Javier, et al.
Publicado: (2012)

Neurochemical changes in animal models of Parkinson’s disease
por: Baranyi, Mária, et al.
Publicado: (2013)

Impact of aging on animal models of Parkinson's disease
por: Klæstrup, Ida Hyllen, et al.
Publicado: (2022)

Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson’s disease
por: Cai, Huaibin, et al.
Publicado: (2014)

Animal Models of Diabetes and Metabolic Disease 2014
por: Sasase, Tomohiko, et al.
Publicado: (2015)

Animal Models of Diabetes and Related Metabolic Diseases
por: Sasase, Tomohiko, et al.
Publicado: (2019)

Animal Experimental Models in Bone Metabolic Disease
por: Usategui-Martín, Ricardo, et al.
Publicado: (2023)

Light-driven activation of mitochondrial proton-motive force improves motor behaviors in a Drosophila model of Parkinson’s disease
por: Imai, Yuzuru, et al.
Publicado: (2019)

Novel modeling methodologies for the neuropathological dimensions of Parkinson's disease
por: Vlamos, Panagiotis
Publicado: (2020)

Longitudinal Metabolomics Profiling of Parkinson’s Disease-Related α-Synuclein A53T Transgenic Mice
por: Chen, Xi, et al.
Publicado: (2015)

The Crucial Roles of Pitx3 in Midbrain Dopaminergic Neuron Development and Parkinson’s Disease-Associated Neurodegeneration
por: Wang, Xin, et al.
Publicado: (2023)

Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson’s Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia
por: Imai, Yuzuru, et al.
Publicado: (2019)

Intracerebroventricular dopamine for Parkinson's disease
por: Devos, David, et al.
Publicado: (2017)

People with Parkinson’s as Partners for the Journal of Parkinson’s Disease
por: McFarthing, Kevin, et al.
Publicado: (2023)

Clinical Manifestations and Molecular Backgrounds of Parkinson's Disease Regarding Genes Identified From Familial and Population Studies
por: Nishioka, Kenya, et al.
Publicado: (2022)

Noninvasive Neuromodulation in Parkinson’s Disease: Insights from Animal Models
por: Muksuris, Katherine, et al.
Publicado: (2023)

Genes, animal models and the current understanding of psychiatric disease
por: Austin, Penelope
Publicado: (2011)

Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice
por: Gu, Xing-Long, et al.
Publicado: (2010)

Therapeutic Effects of Hydrogen in Animal Models of Parkinson's Disease
por: Fujita, Kyota, et al.
Publicado: (2011)

Toxin-Induced and Genetic Animal Models of Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2010)

Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
por: Esposito, Emanuela, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mbrqd733ieaff77lnna8m2ehs7